诱导多能干细胞在恶性固体瘤中的应用
Rong He1, Zhijie Weng1, Yunkun Liu1
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Stem cell reviews and reports
|September 27, 2023
概括
诱导多能干细胞 (iPSCs) 为恶性固体瘤研究提供了新的途径,从建模到新疗法. 本综述探讨了iPSC在癌症治疗中的应用和挑战.
科学领域:
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 恶性固体瘤仍然是一个重大的挑战,治疗结果不令人满意.
- 诱导多能干细胞 (iPSCs) 技术已经进步,为生物研究提供了新的工具.
- 在iPSC中重新编程技术可以影响细胞命运,这与癌症生物学有关.
研究的目的:
- 审查诱导多能干细胞 (iPSCs) 在恶性固体瘤研究中的演变和应用.
- 探索iPSCs在癌症建模,细胞治疗和免疫治疗中的潜力.
- 讨论iPSC技术在瘤学中的挑战和未来方向.
主要方法:
- 在癌症研究中诱导多能干细胞 (iPSCs) 应用的文献综述.
- 分析使用来自不同来源 (体细胞,瘤等) 的iPSCs的研究. ) 的情况.
- 综合了基于iPSC的癌症建模,治疗和进展研究的信息.
主要成果:
- 诱导多能干细胞 (iPSCs) 在模拟恶性固体瘤的各个方面表现出显著的潜力.
- 正在探索iPSC技术用于创新的细胞疗法和抗癌免疫疗法.
- 研究强调了iPSCs在了解瘤进展和患者特异性疾病机制方面的有用性.
结论:
- 诱导多能干细胞 (iPSCs) 在促进恶性固体瘤研究和治疗策略方面是一个有前途的前沿.
- 克服技术和道德障碍对于基于iPSC的癌症治疗的临床转化至关重要.
- 整合iPSC技术有可能彻底改变治疗恶性固体瘤的方法.
更多相关视频
10:57Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
10.4K
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.2K
相关概念视频
01:06Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:19Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
01:17Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K